Heterologous expression of the biosynthetic gene clusters of coumermycin A1, clorobiocin and caprazamycins in genetically modified Streptomyces coelicolor strains

Biopolymers
2010.0

Abstract

<jats:title>Abstract</jats:title><jats:p>The biosynthetic gene clusters of the aminocoumarin antibiotics clorobiocin and coumermycin A<jats:sub>1</jats:sub> and of the liponucleoside antibiotic caprazamycin were stably integrated into the genomes of different host strains derived from <jats:italic>Streptomyces coelicolor</jats:italic> A3(2). For the heterologous expression of clorobiocin derivatives in a chemically defined medium, inclusion of 0.6% of the siloxylated ethylene oxide/propylene oxide copolymer Q2‐5247 into the growth medium proved to result in a 4.8‐fold increase of productivity. Presumably, this copolymer acts as an oxygen carrier. The additional inclusion of cobalt chloride (0.2–2 mg l<jats:sup>−1</jats:sup>) dramatically increased the percentage of the desired compound clorobiocin within the total produced clorobiocin derivatives. This is very likely due to a stimulation of a cobalamin‐dependent methylation reaction catalyzed by the enzyme CloN6 of clorobiocin biosynthesis. All three investigated host strains (<jats:italic>S. coelicolor</jats:italic> M512, M1146 and M1154) gave similar production rates of total clorobiocin derivatives (on average, 158 mg l<jats:sup>−1</jats:sup> in the presence of 0.6% Q2‐5247 and 0.2 mg l<jats:sup>−1</jats:sup> CoCl<jats:sub>2</jats:sub>). In contrast, heterologous production of caprazamycin derivatives was optimal in strain M1154 (amounts of 152 mg l<jats:sup>−1</jats:sup> on average). © 2010 Wiley Periodicals, Inc. Biopolymers 93: 823–832, 2010.

Knowledge Graph

Similar Paper

Heterologous expression of the biosynthetic gene clusters of coumermycin A<sub>1</sub>, clorobiocin and caprazamycins in genetically modified <i>Streptomyces coelicolor</i> strains
Biopolymers 2010.0
Heterologous expression of natural product biosynthetic gene clusters in <i>Streptomyces coelicolor</i>: from genome mining to manipulation of biosynthetic pathways
Journal of Industrial Microbiology and Biotechnology 2014.0
Heterologous expression of natural product biosynthetic gene clusters in <i>Streptomyces coelicolor</i>: from genome mining to manipulation of biosynthetic pathways
Journal of Industrial Microbiology and Biotechnology 2014.0
New Aminocoumarin Antibiotics from a cloQ-Defective Mutant of the Chorobiocin Producer Streptomyces reseochromogenes DS12.976
The Journal of Antibiotics 2004.0
Streptomyces coelicolor as an Expression Host for Heterologous Gene Clusters
Methods in Enzymology 2012.0
Heterologous expression of Streptomyces clavuligerus ATCC 27064 cephamycin C gene cluster
Journal of Biotechnology 2014.0
A chromatogram-simplified Streptomyces albus host for heterologous production of natural products
Antonie van Leeuwenhoek 2020.0
Identification and Heterologous Expression of the Chaxamycin Biosynthesis Gene Cluster from Streptomyces leeuwenhoekii
Applied and Environmental Microbiology 2015.0
The biosynthetic genes for clavulanic acid and cephamycin production occur as a ‘super-cluster’ in three<i>Streptomyces</i>
FEMS Microbiology Letters 1993.0
ChemInform Abstract: CLOROBIOCIN, EIN NEUES, AUS EINER REIHE VON STREPTOMYCES‐STAEMMEN GEWONNENES CHLORHALTIGES ANTIBIOTICUM
Chemischer Informationsdienst 1972.0